Navigation Links
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Therapeutic Pipeline Market Review H1 2015 Available at LifeScienceIndustryResearch.com
Date:3/10/2015

Dallas, Texas (PRWEB) March 11, 2015

The report “Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Radiation Toxicity. Radiation Toxicity is an acute illness caused by a dose greater than 50 rads of penetrating radiation to most or all of the body in a short time, usually a matter of minutes. Common exposures to low-dose radiation, such as X-ray or CT examinations, don't cause radiation sickness. The symptoms are Nausea and vomiting, Diarrhea, Headache, Fever, Dizziness and disorientation, Weakness, fatigue, Hair loss, bloody vomit and stools, infections, poor wound healing, low blood pressure. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.lifescienceindustryresearch.com/radiation-toxicity-radiation-sickness-acute-radiation-syndrome-pipeline-review-h1-2015.html .

The report also reviews key players involved in the therapeutic development for Radiation Toxicity and special features on late-stage and discontinued projects. Companies discussed in this Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Pipeline Review, H1 2015 report include Aeolus Pharmaceuticals, Inc., Bolder Biotechnology, Inc., Cantex Pharmaceuticals, Inc., Cellerant Therapeutics, Inc., Cleveland BioLabs, Inc., Gamida Cell Ltd., Humanetics Corporation, Meabco A/S, NeoStem, Inc., Neumedicines Inc., Onconova Therapeutics, Inc., Piramal Enterprises Limited, Pluristem Therapeutics Inc., Priaxon AG
ProCertus BioPharm Inc., RDD Pharma Ltd., RxBio, Inc., Soligenix, Inc., Terapio Corporation and Tonix Pharmaceuticals Holding Corp.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are 517-PXN, AEOL-10171, BBT-007, BBT-015, BBT-018, BBT-045, BCN-057, BIO-300, BP-C2, CLT-009, EDL-2000, entolimod, EWA-001, GC-003, GC-4403, GC-4419, JP4-039, NMIL-121, P-276, Peptide to Agonize GHSR-1a for Sepsis, Acute Radiation Syndrome and Acute Ischemic Stroke, PGX-100, PLX-RAD, PrC-210, recilisib sodium, Recombinant Protein for Sepsis, Inflammatory bowel disease, Acute radiation syndrome and Ischemic organ injury, romyelocel-L, RP-239X, rusalatide acetate, Rx-100, RX-101, SGX-201, Small Molecule for Radiation Proctitis, Small Molecules for Radiation and Chemical Toxicity, Small Molecules for Radiation Toxicity, Small Molecules to Inhibit NO Synthase for Toxicology, Metabolic and Dermatology, ST-7, Stem Cell Therapy for Radiation Exposure, SY-303A, SY-513 and TPO-7630. Order a purchase copy of this report @ http://www.lifescienceindustryresearch.com/purchase?rname=35679 . (This is a premium report priced at US$2000 for a single user License.)

List of Tables

Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), H1 2015 11
Number of Products under Development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Comparative Analysis, H1 2015 12
Number of Products under Development by Companies, H1 2015 14
Number of Products under Development by Companies, H1 2015 (Contd..1) 15
Number of Products under Investigation by Universities/Institutes, H1 2015 16
Products under Development by Companies, H1 2015 21
Products under Investigation by Universities/Institutes, H1 2015 24
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Aeolus Pharmaceuticals, Inc., H1 2015 25
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Bolder Biotechnology, Inc., H1 2015 26
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Cantex Pharmaceuticals, Inc., H1 2015 27
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Cellerant Therapeutics, Inc., H1 2015 28
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Cleveland BioLabs, Inc., H1 2015 29
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Gamida Cell Ltd., H1 2015 30
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Humanetics Corporation, H1 2015 31
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Meabco A/S, H1 2015 32
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by NeoStem, Inc., H1 2015 33
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Neumedicines Inc., H1 2015 34
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Onconova Therapeutics, Inc., H1 2015 35
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Piramal Enterprises Limited, H1 2015 36
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Pluristem Therapeutics Inc., H1 2015 37
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Priaxon AG, H1 2015 38
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by ProCertus BioPharm Inc., H1 2015 39
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by RDD Pharma Ltd., H1 2015 40
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by RxBio, Inc., H1 2015 41
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline by Soligenix, Inc., H1 2015 42

Explore more reports on Pharmaceuticals industry at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .

About Us:
LifeScienceIndustryResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/radiation-toxicity-market/pipeline-review-h1-2015/prweb12573764.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Balloon mis-positioning during prostate cancer treatment could affect success of radiation delivery
2. Beaumont Health System Research: Accelerated Breast Radiation Treatment Provides Same Outcomes after 10 Years
3. RF Safe List of Lowest Radiation Cell Phones by Specific Absorption Rate (SAR) Levels
4. RF Safe New Year’s Resolutions – Lower Potential Health Risk From Cell Phone Radiation Exposure
5. After Christmas Sale at RF Safe on Air-Tube Headsets That Prevent Radiation Hazards for Kids That Got a New Smartphone for Christmas
6. RF Safe Cell Phone Radiation Shield, Ferrite Bead and Air-tube Headsets Reduce Smartphone Radiation Risk
7. Rf Safe Launches Social Deal Savings On Smart Phone Radiation Safety Accessories
8. RF Safe Cell Phone Radiation Shields Prevent Fetal Radiation Exposure
9. Innovative motion evaluation tool saves patients with back pain X-ray radiation exposure
10. RF Safe Launches Samsung Smartphone Flip Cases To Shield Cell Phone Radiation
11. RF Safe Launches Smartphone Flip Cases for Apple iPhone to Shield Cell Phone Radiation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2020)... ... August 05, 2020 , ... In ... risen to unprecedented challenges. Regardless of the obstacle - shortages of tests, ventilators ... (PPE) and the cancellation or postponement of all nonessential services - providers across ...
(Date:8/5/2020)... ... August 05, 2020 , ... CentrAlert, Inc. today announced ... access to essential COVID-19 information. Know NOW!, which is available for Apple ... unify them in one easy-to-use mobile application. , “When COVID-19 first hit, there was ...
(Date:8/5/2020)... ... , ... Today, Power to Decide’s One Key Question was recognized ... Station Best Practice Award. The One Key Question program is a transformative tool that ... have a child. One Key Question is used by thousands of health care, social ...
(Date:8/3/2020)... ... August 03, 2020 , ... Actuate ... first patients with first-line advanced pancreatic cancer in a phase 2 study of ... 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 ...
(Date:7/31/2020)... ... July 31, 2020 , ... National ... the following statement today regarding the nation’s ongoing preparations for the eventual deployment ... nation with an efficient, effective and essential component of vaccine deployment. They will ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... July 31, 2020 , ... ... Netquest, a global panel and data collection provider, recently released the results of ... the United Kingdom, Germany and France. , “COVID-19 continues to have a major ...
(Date:7/31/2020)... ... July 31, 2020 , ... In an informal poll ... vast majority voted for a refreshed Minnesota Twins “Minnie and Paul” logo that is ... Barton, circa 1960. That was well before the civil rights movement in the United ...
(Date:7/22/2020)... PORTLAND, Ore. (PRWEB) , ... July 22, 2020 ... ... to safely re-open schools is a critical topic receiving national attention. A new ... this critical issue for creating and maintaining safe schools. , The Germ-Fogger™ disinfecting-fogger ...
Breaking Medicine Technology: